Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
Daniel S. Reich(National Institute of Neurological Disorders and Stroke), Sibyl Wray, Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Sara Eichau Maduano, Ema Kantorová(Sanofi (United States)), André Palma da Cunha Matta(Sanofi (United States)), Alla Goloborodko, Radek Ampapa(Hospital Jihlava), Patrick Vermersch(Université de Lille), Robert J. Fox(Cleveland Clinic), Anthony Traboulsee(University of British Columbia), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Eva Meluzínová, Marta Khavunka, И. В. Литвиненко(Unknown), Viera Hančinová, Martin Vališ(Charles University), María Luisa Martínez Ginés, Pavel Štourač, Guillaume Mathey(Inserm), С А Сиверцева, François Grand’Maison, Miroslav Mareš(Pardubice Region), Katrin Gross‐Paju, François Jacques, David Laplaud(Inserm), Douglas L. Arnold(University of Oxford), Daniel Wynn(Consultants in Neurology), N. А. Totolyan, V.M. Pashkovskyy, Amit Bar‐Or(McGill University), Erik Wallström(Novartis (Switzerland)), Timothy J. Turner(Sanofi (United States)), Michaela Týblová, Lluís Ramió‐Torrentà, O. I. Kalbus, Ф. А. Хабиров(Kazan Scientific Center), William Honeycutt, Pavel Hradilke, Evgeny Evdoshenkoo, Volodymyr Pryshchepa, Xinyan Zhang(Obstetrics and Gynecology Hospital of Fudan University), José Meca-Lallana, Sergii Moskovko, Maria Zakharova, Е. В. Попова
Cited by 192
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k